Phosphorus oxychloride → 2-Chloro-7-(1-ethylpropyl)-4-methoxy-1-methyl-1H-benzimidazole
Reaction equation
[CH2:1]([CH:3]([C:6]1[C:11]2[N:12]([CH3:16])[C:13](=O)[NH:14][C:10]=2[C:9]([O:17][CH3:18])=[CH:8][CH:7]=1)[CH2:4][CH3:5])[CH3:2].P(Cl)(Cl)([Cl:21])=O>>[Cl:21][C:13]1[N:12]([CH3:16])[C:11]2[C:6]([CH:3]([CH2:4][CH3:5])[CH2:1][CH3:2])=[CH:7][CH:8]=[C:9]([O:17][CH3:18])[C:10]=2[N:14]=1Participants
3
Conditions
- Temperature
- 110 °C
Procedure
A mixture of 7-(1-ethylpropyl)-4-methoxy-1-methyl-1,3-dihydro-2H-benzimidazol-2-one (190 mg, 0.765 mmol) in phosphorous oxychloride (2.14 mL) was stirred at 110° C. for 6 h. The reaction was allowed to cool to room temperature and concentrated in vacuo. The residue was dissolved in ethyl acetate and washed with aqueous sodium bicarbonate and brine. The organic layer was dried over magnesium sulfate, filtered, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (n-hexane/ethyl acetate 10:1-1:1) and crystallized from ethyl acetate/n-hexane to afford the title compound as colorless crystals (123 mg, 60%).
Workup
- temperatureto cool to room temperature
- concentrationconcentrated in vacuo
- dissolutionThe residue was dissolved in ethyl acetate
- washwashed with aqueous sodium bicarbonate and brine
- dry with materialThe organic layer was dried over magnesium sulfate
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue was purified by column chromatography on silica gel (n-hexane/ethyl acetate 10:1-1:1)
- customcrystallized from ethyl acetate/n-hexane
Sources & evidence
- ORD record
- ord-051f5c5729ba4a7594f3af1c0fe654fd
- Source dataset
- uspto-grants-2012_04
- Patent number
- US08163935B2
Reaction notes
Loading…